News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Argus has lowered its target price for PulteGroup Inc. (PHM) to $138.00, while the current stock price is $129.57. PulteGroup is a U.S. homebuilder focusing on single-family detached homes for various buyer segments. This report is part of a broader set of analyst actions …
Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup negative 36.7%Alterity Therapeutics announced that the U.S. Patent and Trademark Office has granted a new composition of matter patent for ATH434, extending its protection to at least 2045. This patent covers the crystalline mesylate form of ATH434 and methods for treating neurological conditions, strengthening its …
Alterity Therapeutics has been granted a new U.S. composition of matter patent for its lead clinical asset, ATH434, extending its protection to at least 2045. This patent significantly enhances the commercial potential of ATH434, particularly as the company prepares for Phase 3 trials in …
Alterity Therapeutics has secured a key US patent for its lead asset, ATH434, covering its crystalline form and methods for treating neurological conditions. This patent significantly strengthens the company's intellectual property portfolio and extends market protection until at least 2045. The drug is slated …
Eltek Ltd. (NASDAQ: ELTK) announced it will release its financial results for the second quarter of 2026 on Tuesday, August 18, 2026, before the market opens. The company will also host a conference call on the same day at 8:30 a.m. Eastern Time to …
Alterity Therapeutics has been granted a key US patent for its lead clinical asset, ATH434, which is designed to treat neurodegenerative diseases like multiple system atrophy (MSA) and Parkinson's disease. This patent extends protection until at least 2045, significantly enhancing the drug's commercial potential …
PulteGroup Inc. (PHM) stock rose 1.82% to $132.42 on Tuesday, despite a broader market downturn where the S&P 500 and Dow Jones Industrial Average both fell. The company's stock, however, underperformed compared to its competitors. PulteGroup Inc. closed 8.36% below its 52-week high.
Craig-Hallum initiated coverage on Alterity Therapeutics (NASDAQ:ATHE) with a "buy" rating and a $12.00 price target, suggesting a potential upside of over 160% from its current trading price of $4.54. The firm sees Alterity's drug ATH434 for multiple system atrophy as a high-risk, high-reward …
WK survey finds three out of four pet owners want pet prescriptions from their retail pharmacy, creating new growth opportunities for pharmacies and pharmacy technology providers WALTHAM, Mass., August 11, 2026--(BUSINESS WIRE)--Wolters Kluwer Health today announced the availability of Medi-Span® Vet Meds, an embedded …
Sharemaestro market context Price above Trend Line 52 weeks -37.4% · Next-week setup negative 42.8%CCH Tagetik accelerates financial close by 33%, reduces manual workload by 80%, and enables end‑to‑end strategy‑to‑execution performance management MUMBAI, India, August 11, 2026--(BUSINESS WIRE)--Wolters Kluwer, a global leader in professional information, software solutions and services, today announced the successful go live of the CCH® …
Sharemaestro market context Price above Trend Line 52 weeks -37.4% · Next-week setup negative 42.8%Eltek Ltd. (ELTK) announced that all resolutions presented at its Annual General Meeting (AGM) of shareholders on August 11, 2026, were duly adopted. These resolutions, detailed in a proxy statement filed on July 2, 2026, included the re-election of board members, the election of …
Eltek Ltd. (NASDAQ: ELTK) will release its second-quarter 2026 financial results before market open on August 18, 2026, followed by a conference call at 8:30 a.m. Eastern Time. CEO Eli Yaffe and CFO Ron Freund will discuss the results, and a replay will be …
Eltek Ltd director Amit Avraham Foox has filed an initial statement of beneficial ownership (Form 3), indicating his insider status as a director. The filing reports no transactions, no buy or sell activity, and no derivative positions or holdings at this time. This standard …
Natural Alternatives International Inc. (NAII) stock has fallen by 14.16% due to negative sentiment surrounding its latest earnings report, which showed weak margins and a net loss. Despite trading at a deep discount to book value and sales, the company's financial unprofitability and high …
This page provides live quotes and charts for Natural Alternatives International Inc. (NAII), showing its current stock price and a candlestick line chart. It indicates that analyst ratings and earnings information for NAII are currently unavailable. The page also includes general disclaimers about the …
Options traders are showing significant interest in PulteGroup (PHM) stock, with high implied volatility for its September 18, 2026 $50 Call options, suggesting expectations of a large price movement. This comes as PulteGroup holds a Zacks Rank #2 (Buy) and analysts have recently increased …
Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup negative 36.7%Search by ticker symbol or company name and select a result to open its chart.